RESEARCH & PUBLICATIONS CITATIONS Clinical Publications, Alzheimer's Disease Novai Ltd 6/7/21 Clinical Publications, Alzheimer's Disease Novai Ltd 6/7/21 Intranasal Formulation Read More Clinical Publications, Glaucoma, AMD/Retinal Degeneration Novai Ltd 5/26/21 Clinical Publications, Glaucoma, AMD/Retinal Degeneration Novai Ltd 5/26/21 Progress: Lab to Clinic Read More Clinical Publications, Glaucoma Novai Ltd 5/3/21 Clinical Publications, Glaucoma Novai Ltd 5/3/21 Phase II, Glaucoma Read More Clinical Publications, AMD/Retinal Degeneration Novai Ltd 12/3/20 Clinical Publications, AMD/Retinal Degeneration Novai Ltd 12/3/20 Phase II, Wet AMD Read More Optic Neuropathy, pONT Model Novai Ltd 2/25/20 Optic Neuropathy, pONT Model Novai Ltd 2/25/20 Using DARC to assess neuroprotection of nerve growth factor eye drops Read More Alzheimer's Disease, Curcumin Treatment, Arvo Abstract Novai Ltd 7/1/19 Alzheimer's Disease, Curcumin Treatment, Arvo Abstract Novai Ltd 7/1/19 Using DARC to assess neuroprotection of intranasal curcumin in an Alzheimer’s model Read More Curcumin Treatment, Glaucoma Novai Ltd 7/18/18 Curcumin Treatment, Glaucoma Novai Ltd 7/18/18 Using DARC to assess neuroprotection of curcumin eyedrops in a glaucoma model Read More Glaucoma, CoQ10 Novai Ltd 9/4/17 Glaucoma, CoQ10 Novai Ltd 9/4/17 Using DARC to assess neuroprotection of CoQ10 eyedrops in a glaucoma model Read More Clinical Publications, Glaucoma Novai Ltd 4/26/17 Clinical Publications, Glaucoma Novai Ltd 4/26/17 Phase I, Glaucoma Read More Alzheimer's Disease, a2 Adrenergic Agonists Novai Ltd 12/8/16 Alzheimer's Disease, a2 Adrenergic Agonists Novai Ltd 12/8/16 Newly described neuroprotective pathway for a commonly used glaucoma drug (Brimonidine) Read More Rotenone Model, Rosiglitazone Treatment, Parkinson’s Disease Novai Ltd 8/16/16 Rotenone Model, Rosiglitazone Treatment, Parkinson’s Disease Novai Ltd 8/16/16 Using DARC to assess neuroprotection of systemic rosiglitazone in a Parkinson’s model Read More Glaucoma, Adenosine A3R Novai Ltd 8/18/15 Glaucoma, Adenosine A3R Novai Ltd 8/18/15 Using DARC to assess neuroprotection of systemic adenosine A3 in a glaucoma model Read More Optic Neuropathy, Schwann Cell Treatment Novai Ltd 10/16/14 Optic Neuropathy, Schwann Cell Treatment Novai Ltd 10/16/14 Using DARC to demonstrate cell therapy (Schwann cells) in an optic neuropathy model Read More Glaucoma, Beta-Amyloid Target Novai Ltd 8/9/14 Glaucoma, Beta-Amyloid Target Novai Ltd 8/9/14 Using DARC to assess neuroprotection of a systemic Abeta modulator in a glaucoma model Read More Toxicity, DMSO Model Novai Ltd 12/10/13 Toxicity, DMSO Model Novai Ltd 12/10/13 Unexpected low-dose toxicity of the universal solvent DMSO Read More Glaucoma, Dystrophy Hypoxia Model, AMD/Retinal Degeneration Novai Ltd 4/1/13 Glaucoma, Dystrophy Hypoxia Model, AMD/Retinal Degeneration Novai Ltd 4/1/13 Imaging in DRY AMD Read More Glaucoma, Transgenic Model Novai Ltd 1/14/10 Glaucoma, Transgenic Model Novai Ltd 1/14/10 Real-time demonstration of different stages of retinal cell death Read More Light Model, AMD/Retinal Degeneration, Glaucoma Novai Ltd 8/6/09 Light Model, AMD/Retinal Degeneration, Glaucoma Novai Ltd 8/6/09 Using DARC to demonstrate phototoxicity Read More Arvo Abstract, Laser Model, AMD/Retinal Degeneration, Transgenic Model Novai Ltd 5/5/08 Arvo Abstract, Laser Model, AMD/Retinal Degeneration, Transgenic Model Novai Ltd 5/5/08 Using DARC to demonstrate diabetic eye disease Read More Glaucoma, Laser Model, AMD/Retinal Degeneration Novai Ltd 4/11/08 Glaucoma, Laser Model, AMD/Retinal Degeneration Novai Ltd 4/11/08 Using DARC to demonstrate retinal laser toxicity Read More Older Posts
Clinical Publications, Alzheimer's Disease Novai Ltd 6/7/21 Clinical Publications, Alzheimer's Disease Novai Ltd 6/7/21 Intranasal Formulation Read More
Clinical Publications, Glaucoma, AMD/Retinal Degeneration Novai Ltd 5/26/21 Clinical Publications, Glaucoma, AMD/Retinal Degeneration Novai Ltd 5/26/21 Progress: Lab to Clinic Read More
Clinical Publications, Glaucoma Novai Ltd 5/3/21 Clinical Publications, Glaucoma Novai Ltd 5/3/21 Phase II, Glaucoma Read More
Clinical Publications, AMD/Retinal Degeneration Novai Ltd 12/3/20 Clinical Publications, AMD/Retinal Degeneration Novai Ltd 12/3/20 Phase II, Wet AMD Read More
Optic Neuropathy, pONT Model Novai Ltd 2/25/20 Optic Neuropathy, pONT Model Novai Ltd 2/25/20 Using DARC to assess neuroprotection of nerve growth factor eye drops Read More
Alzheimer's Disease, Curcumin Treatment, Arvo Abstract Novai Ltd 7/1/19 Alzheimer's Disease, Curcumin Treatment, Arvo Abstract Novai Ltd 7/1/19 Using DARC to assess neuroprotection of intranasal curcumin in an Alzheimer’s model Read More
Curcumin Treatment, Glaucoma Novai Ltd 7/18/18 Curcumin Treatment, Glaucoma Novai Ltd 7/18/18 Using DARC to assess neuroprotection of curcumin eyedrops in a glaucoma model Read More
Glaucoma, CoQ10 Novai Ltd 9/4/17 Glaucoma, CoQ10 Novai Ltd 9/4/17 Using DARC to assess neuroprotection of CoQ10 eyedrops in a glaucoma model Read More
Clinical Publications, Glaucoma Novai Ltd 4/26/17 Clinical Publications, Glaucoma Novai Ltd 4/26/17 Phase I, Glaucoma Read More
Alzheimer's Disease, a2 Adrenergic Agonists Novai Ltd 12/8/16 Alzheimer's Disease, a2 Adrenergic Agonists Novai Ltd 12/8/16 Newly described neuroprotective pathway for a commonly used glaucoma drug (Brimonidine) Read More
Rotenone Model, Rosiglitazone Treatment, Parkinson’s Disease Novai Ltd 8/16/16 Rotenone Model, Rosiglitazone Treatment, Parkinson’s Disease Novai Ltd 8/16/16 Using DARC to assess neuroprotection of systemic rosiglitazone in a Parkinson’s model Read More
Glaucoma, Adenosine A3R Novai Ltd 8/18/15 Glaucoma, Adenosine A3R Novai Ltd 8/18/15 Using DARC to assess neuroprotection of systemic adenosine A3 in a glaucoma model Read More
Optic Neuropathy, Schwann Cell Treatment Novai Ltd 10/16/14 Optic Neuropathy, Schwann Cell Treatment Novai Ltd 10/16/14 Using DARC to demonstrate cell therapy (Schwann cells) in an optic neuropathy model Read More
Glaucoma, Beta-Amyloid Target Novai Ltd 8/9/14 Glaucoma, Beta-Amyloid Target Novai Ltd 8/9/14 Using DARC to assess neuroprotection of a systemic Abeta modulator in a glaucoma model Read More
Toxicity, DMSO Model Novai Ltd 12/10/13 Toxicity, DMSO Model Novai Ltd 12/10/13 Unexpected low-dose toxicity of the universal solvent DMSO Read More
Glaucoma, Dystrophy Hypoxia Model, AMD/Retinal Degeneration Novai Ltd 4/1/13 Glaucoma, Dystrophy Hypoxia Model, AMD/Retinal Degeneration Novai Ltd 4/1/13 Imaging in DRY AMD Read More
Glaucoma, Transgenic Model Novai Ltd 1/14/10 Glaucoma, Transgenic Model Novai Ltd 1/14/10 Real-time demonstration of different stages of retinal cell death Read More
Light Model, AMD/Retinal Degeneration, Glaucoma Novai Ltd 8/6/09 Light Model, AMD/Retinal Degeneration, Glaucoma Novai Ltd 8/6/09 Using DARC to demonstrate phototoxicity Read More
Arvo Abstract, Laser Model, AMD/Retinal Degeneration, Transgenic Model Novai Ltd 5/5/08 Arvo Abstract, Laser Model, AMD/Retinal Degeneration, Transgenic Model Novai Ltd 5/5/08 Using DARC to demonstrate diabetic eye disease Read More
Glaucoma, Laser Model, AMD/Retinal Degeneration Novai Ltd 4/11/08 Glaucoma, Laser Model, AMD/Retinal Degeneration Novai Ltd 4/11/08 Using DARC to demonstrate retinal laser toxicity Read More
